[PDF][PDF] Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer
K Ng, JA Meyerhardt, K Wu, D Feskanich… - Journal of Clinical …, 2008 - researchgate.net
K Ng, JA Meyerhardt, K Wu, D Feskanich, BW Hollis, EL Giovannucci, CS Fuchs
Journal of Clinical Oncology, 2008•researchgate.netCirculating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer Page
1 Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer
Kimmie Ng, Jeffrey A. Meyerhardt, Kana Wu, Diane Feskanich, Bruce W. Hollis, Edward L.
Giovannucci, and Charles S. Fuchs From the Division of Medical Oncology, Dana-Farber
Cancer Institute; Depart- ments of Nutrition and Epidemiology, Harvard School of Public
Health; Chan- ning Laboratory, Department of Medicine, Brigham and Women’s Hospital, and …
1 Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer
Kimmie Ng, Jeffrey A. Meyerhardt, Kana Wu, Diane Feskanich, Bruce W. Hollis, Edward L.
Giovannucci, and Charles S. Fuchs From the Division of Medical Oncology, Dana-Farber
Cancer Institute; Depart- ments of Nutrition and Epidemiology, Harvard School of Public
Health; Chan- ning Laboratory, Department of Medicine, Brigham and Women’s Hospital, and …
Purpose
Higher plasma 25-hydroxyvitamin D3 (25 (OH) D) levels are associated with a decreased incidence of colorectal cancer, but the influence of plasma 25 (OH) D on the outcome of patients with established colorectal cancer is unknown.
researchgate.net